home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Events -> Courses and Workshops  

Online Webinar on Latest FDA Update and Expectations in September

  August 03, 2016  
Compliance4All, Online Event

The Food and Drug Administration Modernization Act (FDAMA) requires that manufacturers track certain devices when the agency orders them to do so.

Tracking is intended to facilitate notification and recall in the event a device presents a serious risk to health that requires prompt attention. The tracking provisions enacted by SMDA required mandatory tracking even if FDA did not issue an order. Specifically, section 519(e), as added by SMDA, required manufacturers to track if they were registered with FDA under section 510 of the act and engaged in the manufacturer of a device if its failure would be reasonably likely to have serious adverse health consequences, and if that device was either a permanently implantable device or a life-sustaining or life-supporting device used outside a device user facility.

Areas Covered In the Session:
Review the key provisions in the updated FDA guidance on medical device tracking
Understand the regulatory expectations for device tracking
Identify new terms and criteria
Understand the statutory criteria and what changed

Who Will Benefit: 
This webinar will provide an overview and guidance to device manufacturers involved in medical device tracking activities. Employees who will benefit include:
All levels of management and departmental representatives and those who desire a better understanding or a "refresh" overview of the Medical Device Tracking process and FDA’s latest expectations
Regulatory Affairs
Clinical Affairs
Quality and Compliance
Marketing & Sales 
Distributors/Authorized Representatives
Organized by: Event Manager
Invited Speakers: David R. Dills , Global Regulatory Affairs & Compliance Consultant, has an accomplished record with more than 26 years of experience within regulatory affairs, compliance and quality consultative services for early-stage/established Class I/II/III medical devices, IVDs, and bio/pharmaceutical manufacturers on the global landscape. 
Deadline for Abstracts: 2016-09-06
Contact Detail:

Compliance4All DBA NetZealous,
Phone: +1-800-447-9407
Email: support@compliance4All.com
Event Link : http://bit.ly/29UxHiW
Twitter Follow us – https://twitter.com/compliance4all
Facebook Like us – https://www.facebook.com/Compliance4all
Pinterest - https://in.pinterest.com/compliance4all/
E-mail: support@compliance4All.com
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.